Novartis' canakinumab failed to improve survival in Phase III trial
FILE PHOTO: The company’s logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in
Read moreFILE PHOTO: The company’s logo is seen at the new cell and gene therapy factory of Swiss drugmaker Novartis in
Read moreNEW YORK (Reuters) – U.S. President Joe Biden on Wednesday said decisions to end the required wearing of masks –
Read more(Reuters) – Johnson & Johnson’s newly authorized COVID-19 vaccine has started shipping and its top executive said on Monday that
Read more(Reuters) – A panel of expert advisers to the U.S. Food and Drug Administration on Friday voted to recommend authorization
Read more(Reuters) – Drugmakers should test any COVID-19 vaccines that have been retooled to combat new variants of the coronavirus in
Read moreFILE PHOTO: A man walks on the premises of the Vivantes Humboldt hospital, which is under quarantine due to infections
Read more(Reuters) – A laboratory study suggests that the South African variant of the coronavirus may reduce antibody protection from the
Read moreSlideshow ( 2 images )FRANKFURT (Reuters) – The European Union will fast track approvals of coronavirus vaccines adapted to combat
Read moreJOHANNESBURG (Reuters) – South Africa is looking at ways to deploy AstraZeneca’s COVID-19 vaccine after temporarily putting on hold plans
Read more(Reuters) -A U.S. congressional panel is investigating three large meatpacking companies for possible worker-safety violations following reports that hundreds of
Read more